ACTRN12610000277044已完成未知
Real time drug administration and physiological data collection during anaesthesia: observational study to evaluate the validity of current response surface models available in the literature
Department of Anaesthesiology, University of Auckland0 个研究点目标入组 160 人开始时间: 2010年4月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients receiving general anaesthesia from six demographic groups will be studied:
- •* Healthy Adults: 18 - 65 years; body mass index 18.5 - 25 (as defined by the World Health Organisation)
- •* Cardiac bypass patients
- •* Elderly, defined as age > 70 years
- •* Overweight, body mass index > 30
- •* Those who receive total intravenous anaesthesia
- •* American Society of Anesthesiologists (ASA) grade 3-4 patients undergoing emergency surgery
排除标准
- •Patients with neurological dysfunction, head trauma, opioid dependence and renal or hepatic co-morbidities will not be studied
研究者
相似试验
尚未招募
不适用
Pharmacokinetics and Therapeutic Drug Monitoring of Intravenous Sulbactam in PediatricsPK parameters of sulbactam in pediatric patients with proven or suspected multidrug resistance A. baumannii infection receiving intravenous sulbactamSulbactam, TDM, pharmacokinetics, A. baumannnii, pediatricsTCTR20221114001Ratchadapisek Sompoch Research Fund62
进行中（未招募）
1 期
Therapeutic drug monitoring and continuous infusion of antibiotics (beta-lactams) in patients with blood poisoning.BacteraemiaMedDRA version: 20.0Level: LLTClassification code 10003998Term: Bacteraemia, unspecifiedSystem Organ Class: 100000019999EUCTR2015-002562-23-DKHvidore Hospital
Unknown
不适用
Non-invasive, Real-time Anesthetic Drug-monitoring SystemAnesthesiaNCT02776020Rambam Health Care Campus30
尚未招募
不适用
e-Monitoring of Asthma Therapy to Improve Compliance in children.asthma, adherence, inhaled corticosteroids, real time medication monitoring (RTMM), sms-reminderNL-OMON29009Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)220
终止
2 期
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerEstrogen Receptor-positive Breast CancerGastrinomaHER2-negative Breast CancerMucositisOral ComplicationsProgesterone Receptor-positive Breast CancerRecurrent Breast CancerRecurrent Islet Cell CarcinomaRecurrent Renal Cell CancerSomatostatinomaStage III Renal Cell CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerStage IV Renal Cell CancerInsulinomaGlucagonomaPancreatic Polypeptide TumorNCT02273752Emory University2